
ClearPoint Neuro CLPT
$ 13.56
-3.28%
Quarterly report 2025-Q3
added 11-06-2025
ClearPoint Neuro DSO Ratio 2011-2025 | CLPT
Annual DSO Ratio ClearPoint Neuro
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 46.1 | 44.8 | 44.4 | 47.2 | 53.5 | 35.5 | 61.2 | 47 | 55 | 96.8 | 1.4 K | 3.43 K | 32.1 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.43 K | 32.1 | 415 |
Quarterly DSO Ratio ClearPoint Neuro
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42.5 | 39.2 | 45 | - | 41.3 | 34.8 | 34.2 | - | 41.4 | 42 | 44.9 | - | 59.9 | 49.1 | 41.5 | - | 49.5 | 59 | 44 | - | 48.8 | 69.3 | 10.6 | - | 34 | 38.2 | 20.3 | - | 62.3 | 68.4 | 61.4 | - | 50.5 | 43.8 | 41.3 | - | 48.9 | 71.6 | 68.2 | - | 89.2 | 135 | 76.2 | - | 67.6 | 36 | 68.7 | - | 75.8 | 125 | 43.9 | - | 35.9 | 37.5 | 39.4 | - | 31.7 | 50.7 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 135 | 10.6 | 52.7 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
39.2 | - | - | $ 17.2 B | ||
|
Alphatec Holdings
ATEC
|
46.4 | $ 20.95 | -0.1 % | $ 2.99 B | ||
|
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | ||
|
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M | ||
|
Cognyte Software Ltd.
CGNT
|
72 | $ 9.28 | -0.32 % | $ 666 M | ||
|
Apyx Medical Corporation
APYX
|
85.8 | $ 3.54 | 2.91 % | $ 123 M | ||
|
Boston Scientific Corporation
BSX
|
65.7 | $ 95.79 | -0.24 % | $ 141 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
66.9 | $ 303.53 | -0.15 % | $ 8.56 B | ||
|
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | ||
|
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
Electromed
ELMD
|
137 | $ 28.33 | -0.6 % | $ 240 M | ||
|
Bruker Corporation
BRKR
|
57.3 | $ 48.37 | 0.74 % | $ 7.21 K | ||
|
Abbott Laboratories
ABT
|
58.7 | $ 124.66 | -0.14 % | $ 217 B | ||
|
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | ||
|
EDAP TMS S.A.
EDAP
|
91.8 | $ 3.25 | -4.41 % | $ 121 M | ||
|
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
120 | - | - | $ 111 M | ||
|
InMode Ltd.
INMD
|
5.36 | $ 14.81 | 1.3 % | $ 1.17 B | ||
|
IRIDEX Corporation
IRIX
|
45.6 | $ 1.17 | -4.88 % | $ 18.9 M | ||
|
IRadimed Corporation
IRMD
|
56.8 | $ 97.65 | 0.21 % | $ 1.24 B | ||
|
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | ||
|
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | ||
|
LivaNova PLC
LIVN
|
59.4 | $ 62.29 | -0.93 % | $ 3.38 B | ||
|
LENSAR
LNSR
|
34.4 | $ 11.93 | -0.21 % | $ 137 M | ||
|
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
86.7 | $ 158.32 | -0.03 % | $ 11.9 B | ||
|
NanoVibronix
NAOV
|
29.7 | - | - | $ 1.08 M | ||
|
Accuray Incorporated
ARAY
|
69.7 | $ 0.81 | -1.31 % | $ 83.2 M | ||
|
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | ||
|
FONAR Corporation
FONR
|
237 | $ 14.46 | 0.07 % | $ 94.8 M | ||
|
AxoGen
AXGN
|
48 | $ 33.15 | 1.07 % | $ 1.47 B | ||
|
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | ||
|
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | ||
|
CONMED Corporation
CNMD
|
67 | $ 41.41 | 1.57 % | $ 1.28 B | ||
|
OrthoPediatrics Corp.
KIDS
|
68.6 | $ 17.7 | 2.08 % | $ 408 M | ||
|
Globus Medical
GMED
|
76.9 | $ 88.34 | -0.08 % | $ 12 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
60.3 | $ 12.58 | -0.32 % | $ 969 M | ||
|
Aziyo Biologics
AZYO
|
51.9 | - | 1.37 % | $ 20.5 M |